Share-based compensation expense was $376 and $145 for the three months ended March 31, 2026 and March 31, 2025, respectively.

Stock option activity for the three months ended March 31, 2026 was as follows:


	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding at December 31, 2025		6,462,746		$	3.42		6.79	$	90
Granted		—		$	—		—	$	—
Exercised		(170,001	)	$	1.06
Forfeited/expired		(255,000	)	$	5.59
Outstanding at March 31, 2026		6,037,745		$	3.38		5.37	$	7,143
Exercisable at March 31, 2026		4,854,220		$	3.98		5.43	$	4,865

Restricted shares activity for the three months ended March 31, 2026 was as follows:


	Number of Restricted Stock Grants			Weighted Average Grant Date Fair Value
Outstanding at December 31, 2025		2,545,524		$	0.73
Granted		—			—
Vested and issued		—			—
Forfeited		(439,148	)		0.60
Outstanding at March 31, 2026		2,106,376		$	0.76
Exercisable at March 31, 2026		—		$	-

On September 29, 2025, the Board of Directors authorized a $10 million share repurchase for up to 5,687,000 of the Company’s outstanding common stock. Such purchases may be made on the open market, in private transactions and/or pursuant to purchase plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The Company is not obligated to repurchase any specific number of shares, and the timing and actual number of shares repurchased will depend on a variety of factors, including the Company’s stock price, general economic, business and market conditions, and alternative investment opportunities. The Company may discontinue any repurchases of its common stock at any time without prior notice. During the three months ended March 31, 2026, the Company repurchased 2,064,626 shares for an aggregate amount of $6,368 (excluding the 2% Canadian excise tax on stock repurchases). As of March 31, 2026, $661 remains available for repurchases. Shares repurchased by the Company are accounted for when the transaction is settled. As of March 31, 2026, there were 149,229 unsettled share repurchases. Direct costs incurred to acquire the shares are included in the total cost of the shares.

Warrant activity for the three months ended March 31, 2026 was as follows:


	Number of Shares Underlying the Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)
Outstanding at December 31, 2025		15,533,900		$	1.65		2.50
Exercised		(235,000	)	$	1.65
Issued		—		$	-		-
Expired		—		$	-		-
Outstanding at March 31, 2026		15,298,900		$	1.65		2.25